Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Telaprevir, boceprevir, cytochrome P450 and immunosuppressive agents--a potentially lethal cocktail.

× No keyword cloud information.

28 in total

1. Prevention of hepatitis C virus infection by adoptive allogeneic immunotherapy using suicide gene-modified lymphocytes: an in vitro proof-of-concept.

Authors: C Leboeuf; J Roser-Schilder; M Lambotin; S Durand; T Wu; C Fauvelle; B Su; E Bôle-Richard; M Deschamps; C Ferrand; P Tiberghien; P Pessaux; T F Baumert; E Robinet
Journal: Gene Ther Date: 2014-11-13 Impact factor: 5.250

2. Use of protease inhibitors in liver transplant recipients.

Authors: Gary L Davis; Jacqueline G O'Leary
Journal: Gastroenterol Hepatol (N Y) Date: 2012-03

3. A human monoclonal antibody targeting scavenger receptor class B type I precludes hepatitis C virus infection and viral spread in vitro and in vivo.

Authors: Philip Meuleman; Maria Teresa Catanese; Lieven Verhoye; Isabelle Desombere; Ali Farhoudi; Christopher T Jones; Timothy Sheahan; Katarzyna Grzyb; Riccardo Cortese; Charles M Rice; Geert Leroux-Roels; Alfredo Nicosia
Journal: Hepatology Date: 2011-12-16 Impact factor: 17.425

Review 4. Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus.

Authors: A Sidney Barritt; Michael W Fried
Journal: Gastroenterology Date: 2012-05 Impact factor: 22.682

Review 5. Hepatitis C virus reinfection after liver transplant: New chances and new challenges in the era of direct-acting antiviral agents.

Authors: Kerstin Herzer; Guido Gerken
Journal: World J Hepatol Date: 2015-03-27

6. Drug interactions: a primer for the gastroenterologist.

Authors: Christina Teeter Doligalski; Angela Tong Logan; Andrew Silverman
Journal: Gastroenterol Hepatol (N Y) Date: 2012-06

7. [Not Available].

Authors: Mark Hull; Pierre Giguère; Marina Klein; Stephen Shafran; Alice Tseng; Pierre Côté; Marc Poliquin; Curtis Cooper
Journal: Can J Infect Dis Med Microbiol Date: 2014 Impact factor: 2.471

Review 8. Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.

Authors: Caroline M Perry
Journal: Drugs Date: 2012-03-26 Impact factor: 9.546

9. Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence.

Authors: Audrey Coilly; Valérie Furlan; Bruno Roche; Caroline Barau; Coralie Noël; Laurence Bonhomme-Faivre; Teresa Maria Antonini; Anne-Marie Roque-Afonso; Didier Samuel; Anne-Marie Taburet; Jean-Charles Duclos-Vallée
Journal: Antimicrob Agents Chemother Date: 2012-08-20 Impact factor: 5.191

10. Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation.

Authors: Scott W Biggins; James Trotter; Jane Gralla; James R Burton; Kiran M Bambha; Jennifer Dodge; Megan Brocato; Linling Cheng; Matt McQueen; Lisa Forman; Michael Chang; Igal Kam; Gregory Everson; Richard A Spritz; Goran Klintmalm; Hugo R Rosen
Journal: J Hepatol Date: 2013-01-15 Impact factor: 25.083